HPV evaluation for precision detection and possibility stratification
The Aptima HPV report and Aptima HPV 16 18/45 genotype report goal HPV sort that pose the best possibility to girls. 2,3 While other HPV assays desired DNA, the Aptima HPV assays desired mRNA, which research has revealed demonstrates the presence and activities of risky HPV problems. 2,3 The Aptima HPV assay recognizes E6/E7 mRNA, and that is indicative of those HPV malware very likely to cause cervical ailments. 2 The Aptima HPV 16 18/45 genotype assay determines HPV sorts 16, 18 and 45, which can be involving as much as 80% of all invasive cervical malignancies globally. 3,15-16
Assessment female with Aptima HPV assays helps service providers boost attend to each person.
The ThinPrep technique facilitate optimize clinical workflow
The ThinPrep Pap examination is just one of a number of choices when you look at the ThinPrep process. The ThinPrep processors, imagers and examine scopes help improve workflow in laboratories and benefit cytotechnologistsa€™ capacity to determine problems. These tools allow 
accomplished the ThinPrep system and optimize laboratory results and precision in problems detection.
Along with the ThinPrep Pap experience, Hologic remains purchased creating research laboratory with innovative and good cytology options for non-gynecological evaluation needs.
From Pap and HPV screening to the full-range of diagnostic products and cross-divisional creation simillar to the master 3D Mammography assessment for chest health, Hologic brings for women. Our very own hope to provide cutting edge merchandise to meet up the requirements of females all over the world lingers throughout all those things we all does, including in cervical disorder assessment. Working together, you can obtain the aim of conquering cervical problem.
a diverse means for womena€™s holistic medical
For more information on the Aptima + ThinPrep Cervical medical collection, go to HealthDxS.
* Aptima HPV report, Aptima HPV 16 18/45 Genotype substance, Cervista HPV hour examination, Cervista HPV 16/18 examination, Roche cobas HPV ensure that you Hybrid record 2 HPV DNA examination.
Mention: 1. ThinPrep 2000 Processor [instructions for use]. MAN-02624-001, Rev. 005. Marlborough, MA: Hologic, Inc.; 2017. 2. Aptima HPV test [package insert]. AW-12820-001, Rev. 001. San Diego, CA: Hologic, Inc.; 2015. 3. Aptima HPV Genotype 16 18/45 assay [package insert]. AW-12821-001, Rev. 001. North Park, CA: Hologic, Inc.; 2015. 4. Blatt AJ, ainsi, al. Comparison of cervical cancer testing effects among 256,648 women in several scientific procedures. Cancers Cytopathol. 2015;123(5):282-288 [Study integrated ThinPrep, SurePath, Hybrid Capture 2 assay]. 5. Saslow D, ainsi, al. American malignant tumors world, American Our society for Colposcopy and Cervical Pathology, and United states environment for Clinical Pathology assessment information the deterrence and beginning sensors of cervical cancer. CA Cancer Tumors J Clin. 2012; 62(3):147-172. 6. The United States College of Obstetricians and Gynecologists. Application publication 168: Screening for cervical cancers. Obstet Gynecol. 2016;128(4):3111-30. doi:10.1097/ AOG.0000000000001708. 7. locations for disorder controls and reduction. Cervical Malignant Tumors is Preventable. s://www.cdc.gov/vitalsigns/cervical-cancer/index.html. Refreshed December 5, 2014. Accessed November 29, 2017. 8. Nationwide Cancers Institute. SEER Stat Concept Sheets: Cervix Uteri Cancer. ://seer.cancer.gov/statfacts/html/cervix.html. Circulated 2016. Utilized December 4, 2017. 9. State Institutes of Wellness. NIH Concept Blankets: Cervical Cancer. ://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=76. Refreshed March 29, 2013. Utilized December 29, 2017. 10. Hologic, Inc. Facts on data. 11. Hologic, Inc. See Printed Facts: Direct-to-Vial Research. s://healthdxs/en/view-published-data/. Accessed December 29, 2017. 12. Eversole GM, ainsi, al. Tactics of members in the university of American Pathologists interlaboratory assessment program in cervicovaginal cytology, 2006. Arch Pathol Laboratory Med. 2010;134(3):331-5. doi:10.1043/1543-2165-134.3.331. 13. Adegoke O, et al. Cervical Cancer fashions across the nation: A 35-Year Population-Based studies. J Lady Health. 2012;21(10):1031-1037. 14. PrepStain Method [product insert]. 779-07085-00, Rev. F. Burlington, NC: TriPath Imaging, Inc., 2011. 15. Li Letter, et al. Person papillomavirus type circulation in 30,848 invasive cervical varieties of cancer worldwide: differences by physical area, histological type and yr of publishing. Int J Cancers. 128:927-935. doi:10.1002/ijc.25396. 16. De Sanjose S, ainsi, al. 2010. Man papillomavirus genotype attribution in intrusive cervical cancer: a retrospective cross-sectional globally study. Lancet. doi:10.1016/S1470-2045(10)70230-8.
Information provided on this case is supposed for visitors outside the US. Contact “United States Of America” case for products and claims obtainable in the usa.